Home > News > Asensio Announces Investment Opinion on NVE
April 2nd, 2004
Asensio Announces Investment Opinion on NVE
Today Asensio & Company, Inc., with 12 years of experience as a leading independent equity research firm, published two research reports on NVE Corporation (NASDAQ Symbol: NVEC, $50.83) titled "NVEC fails to solve Cypress' MRAM problems" and "Cypress values NVEC at a maximum of $4.85 per share."
Arrowhead to Present at Barclays Global Healthcare Conference March 11th, 2014
Nano Labs Shareholder Update March 8th, 2014
FEI Company Announces Date for Investor Conference Participation March 3rd, 2014
Industrial Nanotech, Inc. Completes On Site Visit by PCAOB Audit Firm - Nears Completion of Audit in Preparation for Move to a Senior Stock Exchange in Late 2014 February 27th, 2014